Verona Pharma PLC
VRNA93.820USD
-0.580-0.61%
종가 06/27, 16:00（ET）시세는 15분 지연됩니다
63.90B시가총액
손실P/E TTM
자세한 내용은 Verona Pharma PLC 회사
Verona Pharma Plc is a United Kingdom-based biopharmaceutical company. The Company is focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. Its product candidate, ensifentrine, is an investigational, inhaled, small molecule and dual inhibitor of the enzyme’s phosphodiesterase 3 and 4 (PDE3 and PDE4) combining bronchodilator and non-steroidal anti-inflammatory activities in one compound. It is engaged in developing inhaled ensifentrine for the treatment of chronic obstructive pulmonary disease (COPD). The Company's two additional formulations of ensifentrine are in Phase II development for the treatment of COPD: dry powder inhaler (DPI) and pressurized metered-dose inhaler (pMDI). The Company's wholly owned subsidiary is Verona Pharma, Inc.
회사 정보
종목 코드 VRNA
회사 이름Verona Pharma PLC
상장일Mar 30, 2005
설립일2005
CEODr. David S. Zaccardelli, Pharm.D.
직원 수209
유형Depository Receipt
회계 연도 종료Mar 30
주소Riverside
도시LONDON
증권 거래소NASDAQ Global Market Consolidated
국가United Kingdom
우편 번호SE1 2RE
전화442032834200
웹사이트https://www.veronapharma.com/
종목 코드 VRNA
상장일Mar 30, 2005
설립일2005
회사 임원
이름
이름/직위
직위
주식 보유
변동
Mr. Mark W. Hahn, CPA
Mr. Mark W. Hahn, CPA
Chief Financial Officer
Chief Financial Officer
677.38K
-53.74%
Dr. David S. Zaccardelli, Pharm.D.
Dr. David S. Zaccardelli, Pharm.D.
President, Chief Executive Officer, Executive Director
President, Chief Executive Officer, Executive Director
391.27K
-50.55%
Mr. Vikas Sinha, CPA
Mr. Vikas Sinha, CPA
Non-Executive Independent Director
Non-Executive Independent Director
74.44K
--
Dr. Mahendra G. Shah, Ph.D.
Dr. Mahendra G. Shah, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
73.08K
+700.00%
Ms. Lisa Deschamps
Ms. Lisa Deschamps
Non-Executive Independent Director
Non-Executive Independent Director
70.32K
+700.00%
Mr. Michael Austwick
Mr. Michael Austwick
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Kathleen Rickard, M.D.
Dr. Kathleen Rickard, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Christina Ackermann
Ms. Christina Ackermann
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Martin William Edwards, M.D.
Dr. Martin William Edwards, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Ben Harber
Mr. Ben Harber
Company Secretary
Company Secretary
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Mark W. Hahn, CPA
Mr. Mark W. Hahn, CPA
Chief Financial Officer
Chief Financial Officer
677.38K
-53.74%
Dr. David S. Zaccardelli, Pharm.D.
Dr. David S. Zaccardelli, Pharm.D.
President, Chief Executive Officer, Executive Director
President, Chief Executive Officer, Executive Director
391.27K
-50.55%
Mr. Vikas Sinha, CPA
Mr. Vikas Sinha, CPA
Non-Executive Independent Director
Non-Executive Independent Director
74.44K
--
Dr. Mahendra G. Shah, Ph.D.
Dr. Mahendra G. Shah, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
73.08K
+700.00%
Ms. Lisa Deschamps
Ms. Lisa Deschamps
Non-Executive Independent Director
Non-Executive Independent Director
70.32K
+700.00%
Mr. Michael Austwick
Mr. Michael Austwick
Non-Executive Independent Director
Non-Executive Independent Director
--
--
수익 분석
데이터 없음
데이터 없음
사업별
지역별
데이터 없음
주식 보유 통계
마지막 업데이트: Sun, May 18
마지막 업데이트: Sun, May 18
주주
주주 유형
주주
주주
비율
Perceptive Advisors LLC
7.71%
Janus Henderson Investors
6.48%
Darwin Global Management Ltd
4.61%
Frazier Life Sciences Management, L.P.
4.06%
Ali (Behbahani)
3.75%
Other
73.39%
주주
주주
비율
Perceptive Advisors LLC
7.71%
Janus Henderson Investors
6.48%
Darwin Global Management Ltd
4.61%
Frazier Life Sciences Management, L.P.
4.06%
Ali (Behbahani)
3.75%
Other
73.39%
주주 유형
주주
비율
Investment Advisor/Hedge Fund
25.31%
Hedge Fund
23.50%
Investment Advisor
16.31%
Private Equity
12.03%
Individual Investor
10.40%
Venture Capital
5.02%
Research Firm
3.63%
Family Office
1.18%
Bank and Trust
0.26%
Other
2.35%
기관 주식 보유
마지막 업데이트: Tue, Mar 4
마지막 업데이트: Tue, Mar 4
보고 기간
기관 수
보유 주식
비율
변동
2025Q1
362
99.25M
116.64%
+16.32M
2024Q4
326
71.46M
84.46%
-16.29M
2024Q3
290
72.06M
88.66%
-13.37M
2024Q2
265
71.81M
88.57%
-10.49M
2024Q1
244
72.12M
89.24%
-7.07M
2023Q4
230
69.67M
87.15%
-7.79M
2023Q3
210
67.04M
84.35%
-7.14M
2023Q2
205
65.57M
82.53%
-8.85M
2023Q1
188
68.22M
86.63%
-3.18M
2022Q4
162
65.88M
87.36%
-542.66K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Perceptive Advisors LLC
6.39M
7.52%
+76.17K
+1.21%
Dec 31, 2024
Janus Henderson Investors
1.67M
1.96%
+624.37K
+59.87%
Dec 31, 2024
Frazier Life Sciences Management, L.P.
3.38M
3.98%
--
--
Dec 31, 2024
Ali (Behbahani)
3.19M
3.76%
+3.19M
--
Jan 16, 2025
Eventide Asset Management, LLC
3.13M
3.69%
+706.28K
+29.11%
Dec 31, 2024
RTW Investments L.P.
1.82M
2.14%
+1.82M
--
Dec 31, 2024
New Enterprise Associates (NEA)
4.08M
4.81%
-1.50M
-26.86%
Jan 16, 2025
Summit Partners Public Asset Management, LLC
1.90M
2.24%
+1.90M
--
Dec 31, 2024
Wellington Management Company, LLP
3.03M
3.56%
+1.15M
+61.03%
Dec 31, 2024
더 보기
관련 ETF
마지막 업데이트: Fri, Jun 6
마지막 업데이트: Fri, Jun 6
이름
비율
ALPS Medical Breakthroughs ETF
5.66%
AdvisorShares Dorsey Wright ADR ETF
5.49%
First Trust IPOX Europe Equity Opportunities ETF
1.67%
First Trust International Equity Opportunities ETF
0.85%
Invesco Nasdaq Biotechnology ETF
0.67%
ProShares Ultra Nasdaq Biotechnology
0.63%
iShares Biotechnology ETF
0.39%
JPMorgan Healthcare Leaders ETF
0.39%
Even Herd Long Short ETF
0.36%
Goldman Sachs Innovate Equity ETF
0.14%
더 보기
ALPS Medical Breakthroughs ETF
비율5.66%
AdvisorShares Dorsey Wright ADR ETF
비율5.49%
First Trust IPOX Europe Equity Opportunities ETF
비율1.67%
First Trust International Equity Opportunities ETF
비율0.85%
Invesco Nasdaq Biotechnology ETF
비율0.67%
ProShares Ultra Nasdaq Biotechnology
비율0.63%
iShares Biotechnology ETF
비율0.39%
JPMorgan Healthcare Leaders ETF
비율0.39%
Even Herd Long Short ETF
비율0.36%
Goldman Sachs Innovate Equity ETF
비율0.14%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
